|
Volumn 105, Issue 4, 2001, Pages 307-311
|
Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis
|
Author keywords
Association; Dopamine receptor; Linkage disequilibrium; RFLP
|
Indexed keywords
DOPAMINE 3 RECEPTOR;
GENE PRODUCT;
PROTEIN BALI;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ALLELISM;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE PREDISPOSITION;
ETHNIC DIFFERENCE;
FAMILIAL DISEASE;
FEMALE;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENOTYPE;
HOMOZYGOSITY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MANIC DEPRESSIVE PSYCHOSIS;
META ANALYSIS;
PRIORITY JOURNAL;
RECEPTOR GENE;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
SCHIZOPHRENIA;
ADULT;
ALLELES;
BIPOLAR DISORDER;
DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC;
DNA;
FEMALE;
GENE FREQUENCY;
GENETIC PREDISPOSITION TO DISEASE;
GENOTYPE;
HUMANS;
MALE;
MIDDLE AGED;
ODDS RATIO;
POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;
RECEPTORS, DOPAMINE D2;
RECEPTORS, DOPAMINE D3;
VARIATION (GENETICS);
|
EID: 0035826544
PISSN: 15524841
EISSN: 1552485X
Source Type: Journal
DOI: 10.1002/ajmg.1353 Document Type: Article |
Times cited : (27)
|
References (24)
|